Keyuan Pharmaceutical (301281.SZ) plans to launch the 2025 Restricted Stock Incentive Plan

According to the Zhitong Finance App, Keyuan Pharmaceutical (301281.SZ) released the 2025 Restricted Stock Incentive Plan (draft). The total number of restricted shares to be granted to incentive recipients is 3 million shares, accounting for about 2.77% of the company's total share capital when the draft incentive plan was announced. Of these, 2.4 million restricted shares were granted for the first time, and 600,000 shares were reserved. The award price is 14.71 yuan/share. The incentive plan is valid for no more than 48 months from the date the restricted shares are first granted until all restricted shares granted to the incentive target are vested or cancelled.